L. Roy Papp & Associates LLP Has $2.59 Million Stock Holdings in The Clorox Company (NYSE:CLX)

L. Roy Papp & Associates LLP decreased its holdings in shares of The Clorox Company (NYSE:CLX) by 4.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 15,871 shares of the company’s stock after selling 715 shares during the period. L. Roy Papp & Associates LLP’s holdings in Clorox were worth $2,586,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. First Foundation Advisors bought a new stake in shares of Clorox in the 1st quarter worth $31,000. Innealta Capital LLC bought a new stake in shares of Clorox in the 2nd quarter worth $30,000. Trifecta Capital Advisors LLC grew its stake in shares of Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after acquiring an additional 130 shares in the last quarter. Quarry LP grew its stake in shares of Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after acquiring an additional 114 shares in the last quarter. Finally, Family Firm Inc. bought a new stake in shares of Clorox in the 2nd quarter worth $31,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Transactions at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.51% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the stock. TD Cowen assumed coverage on shares of Clorox in a research note on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 target price for the company. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a research report on Friday, September 6th. Wells Fargo & Company reduced their price target on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research report on Wednesday, July 10th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Finally, DA Davidson restated a “neutral” rating and set a $153.00 price target on shares of Clorox in a research report on Friday, September 6th. Six investment analysts have rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $150.14.

Clorox Stock Performance

NYSE CLX traded down $2.29 during trading on Friday, hitting $156.69. 1,040,134 shares of the company’s stock traded hands, compared to its average volume of 1,223,216. The stock has a market capitalization of $19.46 billion, a price-to-earnings ratio of 81.19, a PEG ratio of 3.19 and a beta of 0.41. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $169.09. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03. The business has a 50 day moving average of $160.74 and a 200-day moving average of $145.62.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The firm had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.97 billion. As a group, equities research analysts anticipate that The Clorox Company will post 6.64 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be issued a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.11%. The ex-dividend date is Wednesday, October 23rd. Clorox’s payout ratio is 252.85%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.